Form 483

Nanovis LLC Form 483, 2026-03-19

FDA issued a Form 483 to Nanovis LLC on 2026-03-19 with 6 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health6 observations

Nanovis LLC · Columbia City, United States · Issued March 19, 2026

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Mar 2026
ISO 13485:2016 Clause 4.1.4

Changes to the QMS not adequately controlled or evaluated

Cited by Suyang Qin, Shawn Choi

19 Mar 2026
ISO 13485:2016 Clause 6.4.1

Work environment requirements and procedures not documented

Cited by Suyang Qin, Shawn Choi

19 Mar 2026
ISO 13485:2016 Clause 7.4.2

Purchasing information does not include all required elements

Cited by Suyang Qin, Shawn Choi

19 Mar 2026
ISO 13485:2016 Clause 7.5.1

Production controls not adequate

Cited by Suyang Qin, Shawn Choi

19 Mar 2026
ISO 13485:2016 Clause 7.5.6

Procedures for validation of processes lack required elements

Cited by Suyang Qin, Shawn Choi

Inspected site

NLNanovis LLCColumbia City, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
ISO 13485:2016 Clause 4.1.4Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 6.4.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.4.2Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.5.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.5.6Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.5.1Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere